Patent details

EP1322324 Title: Botulinum toxin for use in the treatment of acute injuries to skeletal muscles

Basic Information

Publication number:
EP1322324
PCT Application Number:
PCT/US/2001/027193
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019664820
PCT Publication Number:
WO/2002/028425
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Botulinum toxin for use in the treatment of acute injuries to skeletal muscles
French Title of Invention:
Toxine botulinique pour son utilisation dans le traitement de lésions aigues des muscles squelettiques
German Title of Invention:
Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln
SPC Number:

Dates

Filing date:
31/08/2001
Grant date:
18/08/2010
EP Publication Date:
18/08/2010
PCT Publication Date:
11/04/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/07/2003
EP B1 Publication Date:
18/08/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
31/08/2010
Expiration date:
31/08/2021
Renunciation date:
Revocation date:
05/06/2018
Annulment date:

Owner

From:
31/08/2001
 
 

Name:
ALLERGAN INC.
Address:
2525 Dupont Drive, Irvine CA 92612, United States (US)

Inventor

1

Name:
BROOKS Gregory, F.
Address:
United States (US)

2

Name:
AOKI Kei, Roger
Address:
United States (US)

Priority

Priority Number:
678189
Priority Date:
04/10/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/48;

Publication

European Patent Bulletin

Issue number:
201849
Publication date:
05/12/2018
Description:
Revocation of the European patent
Filing date Document type Number of pages